DK406484A - 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf - Google Patents

16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf Download PDF

Info

Publication number
DK406484A
DK406484A DK406484A DK406484A DK406484A DK 406484 A DK406484 A DK 406484A DK 406484 A DK406484 A DK 406484A DK 406484 A DK406484 A DK 406484A DK 406484 A DK406484 A DK 406484A
Authority
DK
Denmark
Prior art keywords
hydroprostanoids
flour
intermediates
procedures
producing
Prior art date
Application number
DK406484A
Other languages
English (en)
Other versions
DK406484D0 (da
Inventor
Franco Faustini
Alessio Roberto D
Achille Panzeri
Enrico Di Salle
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of DK406484D0 publication Critical patent/DK406484D0/da
Publication of DK406484A publication Critical patent/DK406484A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
DK406484A 1983-09-07 1984-08-24 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf DK406484A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838324004A GB8324004D0 (en) 1983-09-07 1983-09-07 16-fluoro-16 17-didehydro prostanoids

Publications (2)

Publication Number Publication Date
DK406484D0 DK406484D0 (da) 1984-08-24
DK406484A true DK406484A (da) 1985-03-08

Family

ID=10548451

Family Applications (1)

Application Number Title Priority Date Filing Date
DK406484A DK406484A (da) 1983-09-07 1984-08-24 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf

Country Status (24)

Country Link
US (1) US4626597A (da)
JP (1) JPS6072859A (da)
KR (1) KR850002830A (da)
AU (1) AU562725B2 (da)
BE (1) BE900414A (da)
CH (1) CH662114A5 (da)
CS (1) CS259869B2 (da)
DE (1) DE3430626A1 (da)
DK (1) DK406484A (da)
ES (2) ES8607022A1 (da)
FI (1) FI843285A (da)
FR (1) FR2551436B1 (da)
GB (2) GB8324004D0 (da)
GR (1) GR80204B (da)
HU (1) HU192430B (da)
IL (1) IL72749A (da)
IT (1) IT1180210B (da)
NL (1) NL8402666A (da)
NO (1) NO843355L (da)
NZ (1) NZ209294A (da)
PT (1) PT79113B (da)
SE (1) SE8404334L (da)
SU (1) SU1442070A3 (da)
ZA (1) ZA846580B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625326D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Medicaments
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
AU616564B2 (en) * 1988-09-29 1991-10-31 Sumitomo Chemical Company, Limited Novel pyrazole compounds, method for production thereof, use thereof and intermediates for production thereof
US5099644A (en) * 1990-04-04 1992-03-31 General Electric Company Lean staged combustion assembly
WO1998021181A2 (en) * 1996-11-12 1998-05-22 Alcon Laboratories, Inc. 15-fluoro prostaglandins as ocular hypotensives
US6680339B2 (en) 1996-11-12 2004-01-20 Alcon Manufacturing, Ltd. 15-fluoro prostaglandins as ocular hypotensives
CN1639117A (zh) * 2002-03-01 2005-07-13 阿勒根公司 前列腺酰胺的制备

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987087A (en) * 1971-07-29 1976-10-19 The Upjohn Company Phenyl-substituted prostaglandin-f type analogs
GB1396206A (en) * 1972-04-27 1975-06-04 Upjohn Co Prostaglandins and the preparation thereof
ZA744580B (en) * 1973-07-20 1975-07-30 Upjohn Co Prostaglandin analogs
US4059576A (en) * 1973-08-06 1977-11-22 Hoffmann-La Roche, Inc. 11-Substituted prostaglandins
GB1484591A (en) * 1974-04-11 1977-09-01 Ono Pharmaceutical Co Prostaglandin compositions
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
US4268522A (en) * 1976-06-14 1981-05-19 Pfizer Inc. 13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
US4283417A (en) * 1976-06-14 1981-08-11 Pfizer Inc. Bronchodialation with 13,14-dihydro-15-alkenyl prostaglandins

Also Published As

Publication number Publication date
PT79113A (en) 1984-09-01
GR80204B (en) 1985-01-02
NL8402666A (nl) 1985-04-01
FI843285A0 (fi) 1984-08-20
GB8324004D0 (en) 1983-10-12
IL72749A0 (en) 1984-11-30
IT1180210B (it) 1987-09-23
KR850002830A (ko) 1985-05-20
CS636084A2 (en) 1988-04-15
SE8404334L (sv) 1985-03-08
GB2146325B (en) 1987-04-01
ES543776A0 (es) 1986-01-16
CS259869B2 (en) 1988-11-15
AU562725B2 (en) 1987-06-18
ES8604135A1 (es) 1986-01-16
FR2551436A1 (fr) 1985-03-08
NZ209294A (en) 1988-03-30
DE3430626A1 (de) 1985-04-04
AU3223184A (en) 1985-03-14
ES8607022A1 (es) 1986-05-16
IL72749A (en) 1988-05-31
SE8404334D0 (sv) 1984-08-30
CH662114A5 (de) 1987-09-15
US4626597A (en) 1986-12-02
NO843355L (no) 1985-03-08
PT79113B (en) 1986-11-14
HUT35638A (en) 1985-07-29
FI843285A (fi) 1985-03-08
HU192430B (en) 1987-06-29
GB2146325A (en) 1985-04-17
ZA846580B (en) 1985-05-29
JPS6072859A (ja) 1985-04-24
GB8421124D0 (en) 1984-09-26
DK406484D0 (da) 1984-08-24
IT8422159A0 (it) 1984-08-01
SU1442070A3 (ru) 1988-11-30
BE900414A (fr) 1985-02-25
ES535551A0 (es) 1986-05-16
FR2551436B1 (fr) 1987-02-27

Similar Documents

Publication Publication Date Title
NO171364C (no) N-aryl-3-aryl-4,5-dihydro-1h-pyrazol-1-karboksamider og fremgangsmaate til fremstilling derav, samt insektmiddel sominneholder karboksamidet
NO863223D0 (no) Sikteanordning og fremgangsmaate ved sikting.
DK332583D0 (da) N-methyl-11-aza-10-deoxo-10-dihydroerythromycin a, mellemprodukter herfor og fremgangsmader til fremstilling deraf
DK186981A (da) 17-substitueret-6-desoxy-7,8-dihydro-6alfa-methylnoroxymorphon samt fremgangsmaade til fremstilling deraf
KR870700614A (ko) -1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
IT1214533B (it) 2-osso-1 solfonil sostituito amminocarbonil azetidine e procedimento per ottenerle.
DK436981A (da) Fremgangsmaade til fremstilling af 25-hydroxy26,26,26,27,27,27,-hexafluor-cholecalciferol og mellemprodukter herved
NO855157L (no) Fremgangsmaate ved fremstilling av cellulosemasse.
DK474585D0 (da) Fremgangsmaade til mikroindkapsling
NO854657L (no) Fremgangsmaate ved fremstilling av isosilybinfri silibin.
NO855026L (no) Aminoacyllabdaner og fremgangsmaate til fremstilling derav.
DE3574482D1 (de) Hydrofinishingverfahren.
FI861107A (fi) Metallurgisk process iii.
DE3583355D1 (de) Gaerungsverfahren.
NO853376L (no) Broenn-testemetode.
NO156204C (no) Polykarbonatformlegeme og fremgangsmaate for dets fremstilling.
DK406484D0 (da) 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf
NO166132C (no) Kjemisk forbindelse og fremgangsmaate til fremstilling derav.
IT8423765A0 (it) Procedimento per produrre 4-alcossianiline.
DE3579802D1 (de) Kaskadenentwachsungsverfahren.
DK179784D0 (da) Krystallinsk zinksilicat, fremgangsmade til dets fremstilling samt dets anvendelse
DE3676753D1 (de) Stranggiessverfahren.
FI852121A0 (fi) Vattenavskiljare foer analyseringsapparat foer gas.
NO851957L (no) Fremgangsmaate til hjelp ved isbryting.
DK247884A (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider, fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment